
Mytos builds robots that grow human cells. Our machines take stem cells as input, and grow them into specific cells like neurons or heart cells. Customers use our platform to scale stem-cell derived therapies to more patients sooner. We're also used to produce cells for testing new drugs on during R&D in Drug Discovery. Mytos is backed by leading investors, including YCombinator, Buckley Ventures and IQ Capital - as well as founders and execs from companies like Kite, Sana, Dropbox, and Revolut. Our team is made up of brilliant engineers from companies like Dyson and Autodesk - working hand-in-hand with Nature-published scientists. We're hiring now - visit our website to see open positions

Mytos builds robots that grow human cells. Our machines take stem cells as input, and grow them into specific cells like neurons or heart cells. Customers use our platform to scale stem-cell derived therapies to more patients sooner. We're also used to produce cells for testing new drugs on during R&D in Drug Discovery. Mytos is backed by leading investors, including YCombinator, Buckley Ventures and IQ Capital - as well as founders and execs from companies like Kite, Sana, Dropbox, and Revolut. Our team is made up of brilliant engineers from companies like Dyson and Autodesk - working hand-in-hand with Nature-published scientists. We're hiring now - visit our website to see open positions
What they do: Build automated robots (iDEM) to grow stem-cell derived human cells and operate an automated CDMO for regenerative-medicine production
HQ: London, United Kingdom
Founders: Ali Afshar and Ignacio Willats
Funding: Company states >$24M raised; reports reference a ~$19M Series A
Employee count: 48
Scaling manufacturing of stem-cell derived therapies and producing consistent, high-throughput human cells for therapeutic and drug-discovery use cases.
Biotechnology Research
$19.0M
Reported by dealroom and company newsroom
“Includes investors such as Wing Venture Capital, IQ Capital, and Buckley Ventures; additional angels and founders/executives from technology and biotech companies are listed as backers”
| Company |
|---|
Company Name: Mytos
Location: London
Employment Type: Full-Time
Department: Software
You rarely get the chance to change an entire industry. But that's the position we find ourselves in. Join us, and you’ll unleash scientists, accelerate their research, and help get cures to patients sooner.
Job Title: Senior Software Engineer (Platform & Security)
Location: London
Employment Type: Full-Time
Department: Software
As a Senior Software Engineer focused on Platform & Security, you'll take a leading role in evolving and maturing our security and compliance posture while building robust infrastructure for our cell manufacturing platform. Mytos is already SOC 2 Type 2 audited, but as our customers move from research into production of cell therapies, they need our technology to be suitable for GMP environments.
We're building a team that enjoys moving fast, strives for continuous improvement, and is passionate about solving real-world problems. If you're excited about solving interesting problems at the intersection of software, hardware, and biology while helping us prepare for the next phase of our growth, we want to hear from you!